Evidence map›Paper›PMID 39825715›Full record

ArticleThe Clinical neuropsychologist2025

Differences and contributors to global cognitive performance in the underrepresented Latinx Parkinson's disease population.

Saar Anis, Henry Mauricio Chaparro-Solano, Thiago Peixoto Leal, Scott A Sperling, Claire Sonneborn, Camila Callegari Piccinin, Miguel Inca-Martinez, Mario Cornejo-Olivas, Maryenela Illanes-Manrique, Pedro Chana-Cuevas and 38 more

Abstract read
In one paragraph

Article in The Clinical neuropsychologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Saar AnisCenter for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Henry Mauricio Chaparro-SolanoGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Thiago Peixoto LealGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Scott A SperlingCenter for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0001-7454-0534
Claire SonnebornQuantitative Health Sciences, Learner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Camila Callegari PiccininCenter for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Miguel Inca-MartinezGenomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Mario Cornejo-OlivasNeurogenetics Working Group, Universidad Cientifica del Sur, Lima, Peru.
Maryenela Illanes-ManriqueNeurogenetics Working Group, Universidad Cientifica del Sur, Lima, Peru.
Pedro Chana-CuevasCentro de Trastornos Del Movimiento (CETRAM), Facultad de Ciencias Medicas, Universidad de Santiago de Chile, Santiago, Chile.
Paula Safie AwadCentro de Trastornos Del Movimiento (CETRAM), Facultad de Ciencias Medicas, Universidad de Santiago de Chile, Santiago, Chile.
Ana Jimena Hernández-MedranoLaboratorio Clínico de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
Amin Cervantes-ArriagaLaboratorio Clínico de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
Artur F S SchuhDepartamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Carlos R M RiederDepartamento de Clínica Médica, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Brazil.
Pedro Braga-NetoDepartment of Clínical Medicine, Faculty of Medicine, Federal University of Ceará Center of Health Sciences, State University of Ceará, Fortaleza, Brazil.
Antonio Andrei da Silva SenaCenter of Health Sciences, State University of Ceará, Fortaleza, Brazil.
Bruno Lopes Santos-LobatoLaboratório de Neuropatologia Experimental, Universidade Federal do Pará, Pará, Brazil.
Emilia M GattoHospital Sanatorio de la Trinidad Mitre, Instituto de Nueurociencias Buenos Aires, University of Buenos Aires, Buenos Aires, Argentina.
Griselda J AlvaradoServicio de Neurología, Hospital Angel Cruz Padilla, San Miguel de Tucuman, Argentina.
Cesar L AvilaInstituto de Investigación en Medicina Molecular y Celular Aplicada (IMMCA), CONICET-UNT-SIPROSA, San Miguel de Tucumán, Argentina.
Vitor TumasDepartment of Neurosciences and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Maria Paula FossDepartment of Neurosciences and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Vanderci BorgesMovement Disorder Unit, Universidade Federal de São Paulo, São Paulo, Brazil.
Henrique Ballalai FerrazMovement Disorder Unit, Universidade Federal de São Paulo, São Paulo, Brazil.
Jorge Luis Orozco VélezFundación Hospital Universitario Valle del lili, Unidad de Neurología, Trastornos del Movimiento, Cali, Colombia.
Beatriz Muñoz OspinaFacultad de Ciencias Humanas, Universidad Icesi, Cali, Colombia.
Sonia MorenoGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
David PinedaGrupo de Neurociencias de Antioquia, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Julia Esther Rios PintoUniversidad Peruana Los Andes, Huancayo, Perú.
Patricio OlguínPrograma de Genética Humana, Departamento de Neurociencia, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Juan Cristobal NuñezDepartamento de Neurología y Neurocirugía Norte, Hospital Clínico Universidad de Chile, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Angel ViñuelaFundacion Parkinson Puerto Rico, Universidad San Juan Bautista, Caguas, Puerto Rico.
Alan O Espinal-MartinezFundacion Parkinson Puerto Rico. Universidad Autonoma de Guadalajara, Jalisco, Mexico.
Nicanor MoriHospital Nacional Daniel Alcides Carrion, Callao, Perú.
Koni Mejía-RojasHospital Nacional Daniel Alcides Carrion, Callao, Perú.
Angel Medina-ColqueUniversidad Nacional del Altiplano, Dirección Regional de Salud de Puno, Puno, Peru.
Ana Lucia Zuma RossoClementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Celmir VilaçaClementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Edward Ochoa-ValleHospital Regional del Cusco, Cusco, Peru.
Iván Cornejo-HerreraHospital Hipólito Unanue de Tacna, Tacna, Peru.
Paula Reyes-PerezLaboratorio Internacional de Investigación Sobre el Genoma Humano, Universidad Nacional Autónoma de México, Santiago de Querétaro, México.
Alejandra Lázaro-FigueroaLaboratorio de Neurogenómica Cognitiva, Unidad de Investigación en Psicobiología y Neurociencias, Facultad de Psicología, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, México.
Anna Letícia de Moraes AlvesMovement Disorders Center, Department of Neurology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
Rubens Gisbert CuryMovement Disorders Center, Department of Neurology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
Hubert H FernandezHospital Hipólito Unanue de Tacna, Tacna, Peru.
Ignacio MataCenter for Neurological Restoration, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Latin American Research consortium on the Genetics of Parkinson’s Disease (LARGE-PD)

Funding

Modeling the impact of Women's Specific Health Factors in PD outcomes in LatinasR01NS112499 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI FERNANDEZ MATA, IGNACIO · 2020 to 2024
$3.3M
NINDS NIH HHS R01 NS112499
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CognitionCognitive DysfunctionHispanic or LatinoParkinson DiseaseAgedCross-Sectional StudiesFemaleHumansMaleMental Status and Dementia TestsMiddle AgedNeuropsychological TestsRetrospective StudiesWhitecognitive dysfunctioncognitive functionLatinxMontreal cognitive assessmentParkinson’s disease

Identifiers

PMID39825715
PMCPMC12766622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.